| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/29/1999 | CA2306796A1 Novel modified msp-1 nucleic acid sequences and methods for increasing mrna levels and protein expression in cell systems |
| 04/29/1999 | CA2306777A1 Method for screening full-length cdna clones |
| 04/29/1999 | CA2306731A1 Using polyamide nucleic acid oligomers to engender a biological response |
| 04/29/1999 | CA2306693A1 Cell lines useful for in vitro assay for identification of carcinogens |
| 04/29/1999 | CA2306631A1 High surface density covalent immobilization of oligonucleotide monolayers |
| 04/29/1999 | CA2306457A1 Secreted proteins and polynucleotides encoding them |
| 04/29/1999 | CA2306454A1 Bacterial resistance in grapevine |
| 04/29/1999 | CA2306445A1 Documentation means for repertoires of nkr immunoreceptors and/or activatory or non-inhibitory immunoreceptor counterparts of nkr immunoreceptors |
| 04/29/1999 | CA2306252A1 Gene delivery vectors and their uses |
| 04/29/1999 | CA2306251A1 Alpha-7 nicotinic receptor |
| 04/29/1999 | CA2305888A1 Zoogloeal and hyphomicrobium spp. nucleic acids |
| 04/29/1999 | CA2305385A1 Human toll homologues |
| 04/29/1999 | CA2273193A1 Novel human .beta.2 integrin alpha subunit |
| 04/28/1999 | EP0911633A1 A method of identifying agonists and antagonists for tumor necrosis related receptors TR1, TR3 and TR5 |
| 04/28/1999 | EP0911416A2 Protein production process |
| 04/28/1999 | EP0911413A2 Minimal adenovirus-based gene therapy vector |
| 04/28/1999 | EP0911412A1 Vector for gene transfer into plant allowing optional deletion of marker gene |
| 04/28/1999 | EP0911411A1 Novel amino-terminal deblocking enzyme |
| 04/28/1999 | EP0911410A2 Era polynucleotides and polypeptides from Streptococcus pneumoniae belonging to the GTPase family |
| 04/28/1999 | EP0911409A2 Deformylase |
| 04/28/1999 | EP0911408A2 DNA coding for serine/threonine kinase |
| 04/28/1999 | EP0911407A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC |
| 04/28/1999 | EP0911406A2 Histidine kinase from Staphylococcus aureus |
| 04/28/1999 | EP0911405A2 Gapdh |
| 04/28/1999 | EP0911404A2 Recoding DNA sequences for expression in yeast and transformed yeasts obtained |
| 04/28/1999 | EP0911403A2 MurB gene from Streptococcus pneumoniae |
| 04/28/1999 | EP0911402A2 PyrR homolog from Staphylococcus aureus |
| 04/28/1999 | EP0911401A1 Muteins of interleukin 4 showing low-affinity and short-term interaction with the common gamma chain |
| 04/28/1999 | EP0911400A1 Antisense compounds to cd14 |
| 04/28/1999 | EP0911399A2 A kringle-related clone, HTHBZ47 |
| 04/28/1999 | EP0911398A2 Phosphorylation epitopes of Tau protein for the diagnosis and treatment of Alzheimer's disease |
| 04/28/1999 | EP0911397A1 Tumor antigen proteins, genes thereof, and tumor antigen peptides |
| 04/28/1999 | EP0911396A2 Methods for generating polynucleotides having desired characteristics by iterative selective and recombination |
| 04/28/1999 | EP0911395A2 Fused cell line and method of obtaining the same |
| 04/28/1999 | EP0911394A2 Use of aluminium compounds |
| 04/28/1999 | EP0911393A1 Novel peptide, process for the production of the same, and use of the same |
| 04/28/1999 | EP0911392A1 Epoxide hydrolase |
| 04/28/1999 | EP0911391A2 A clone HWHHJ20 |
| 04/28/1999 | EP0911390A2 Protein kinases as tools for the diagnosis and treatment of Alzheimer's disease |
| 04/28/1999 | EP0911388A2 Method for stimulation of T-cells with desired antigenspecificity |
| 04/28/1999 | EP0911342A1 Novel protein and process for producing the same |
| 04/28/1999 | EP0911341A1 Adenine nucleotide translocator |
| 04/28/1999 | EP0911033A2 Methods and compositions for the treatment of diseases with interferon while reducing side effects |
| 04/28/1999 | EP0910670A1 Covalent attachment of nucleic acid molecules onto solid-phases via disulfide bonds |
| 04/28/1999 | EP0910669A1 Isolated nucleic acid molecules which are members of the mage-b family and uses thereof |
| 04/28/1999 | EP0910667A1 Nucleotide probes and method for determining hla dqb1 typing |
| 04/28/1999 | EP0910665A1 Identification of numerical changes in cell dna |
| 04/28/1999 | EP0910663A1 Methods and compositions for determining the tumor suppressor status of cells |
| 04/28/1999 | EP0910662A1 Methods and reagents for typing hla class i genes |
| 04/28/1999 | EP0910659A2 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 04/28/1999 | EP0910658A1 Protein expression system |
| 04/28/1999 | EP0910657A1 Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus |
| 04/28/1999 | EP0910656A1 Virus-like particles useful as a vector for delivering nucleic acid |
| 04/28/1999 | EP0910655A1 Vaccines for treatment of lymphoma and leukemia |
| 04/28/1999 | EP0910654A1 Enzyme combinations for destroying proliferative cells |
| 04/28/1999 | EP0910653A2 A cytoplasmic gene expression system which utilizes a prokaryotic rna polymerase autogene |
| 04/28/1999 | EP0910652A1 Hormone-mediated methods for modulating expression of exogenous genes in mammalian systems, and products related thereto |
| 04/28/1999 | EP0910651A1 Ozone-induced gene expression in plants |
| 04/28/1999 | EP0910650A1 Transgenic plants expressing rabies glycoprotein g, and glycoproteins thus obtained |
| 04/28/1999 | EP0910649A1 Genetic constructs and methods for producing fruits with very little or diminished seed |
| 04/28/1999 | EP0910648A1 Soluble 7-transmembrane domain g-protein-coupled receptor compositions and methods |
| 04/28/1999 | EP0910647A1 Human dnase i hyperactive variants |
| 04/28/1999 | EP0910646A1 Brain glycogen phosphorylase cancer antigen |
| 04/28/1999 | EP0910645A1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF I-kappa-B-alpha |
| 04/28/1999 | EP0910644A1 Retinoid metabolizing protein |
| 04/28/1999 | EP0910643A1 Ribonuclease resistant rna preparation and utilization |
| 04/28/1999 | EP0910642A1 A method for increasing hemoprotein production in filamentous fungi |
| 04/28/1999 | EP0910641A1 Neural cell adhesion molecule splicing variants |
| 04/28/1999 | EP0910640A2 Peptides and peptidomimetic compounds affecting the activity of g-protein-coupled receptors by altering receptor oligomerization |
| 04/28/1999 | EP0910639A1 HUMAN cAMP-DEPENDENT PROTEIN KINASE INHIBITOR HOMOLOG |
| 04/28/1999 | EP0910638A2 Polynucleotide encoding secreted proteins |
| 04/28/1999 | EP0910637A1 Polynucleotide encoding secreted protein isolated from human dendritic cells |
| 04/28/1999 | EP0910636A1 Human b-cell antigens, related reagents |
| 04/28/1999 | EP0910635A1 Hematopoietic cytokine receptor |
| 04/28/1999 | EP0910634A2 ANTISENSE INHIBITORS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEgF/VPF) EXPRESSION |
| 04/28/1999 | EP0910633A2 Polyketides and their synthesis |
| 04/28/1999 | EP0910628A1 Inactivation resistant factor viii |
| 04/28/1999 | EP0910627A1 A recombinant enzyme with dextranase activitiy |
| 04/28/1999 | EP0910623A1 Thrombin receptor modified transgenic animals |
| 04/28/1999 | EP0910578A2 Recombinant expression of proteins from secretory cell lines |
| 04/28/1999 | EP0910577A2 Hypertonia gene |
| 04/28/1999 | EP0910571A2 Novel antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis |
| 04/28/1999 | EP0910570A1 Integrated nucleic acid hybridization devices based upon active surface chemistry |
| 04/28/1999 | EP0910569A1 Extracellular/epidermal growth factor-like protein |
| 04/28/1999 | EP0910467A1 Electrochemical solid phase synthesis of polymers |
| 04/28/1999 | EP0910409A1 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens |
| 04/28/1999 | EP0910406A1 Recombinant canine herpesviruses |
| 04/28/1999 | EP0910405A2 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection |
| 04/28/1999 | EP0910403A1 Stationary phase, stress response sigma factor from mycobacterium tuberculosis, and regulation thereof |
| 04/28/1999 | EP0910401A1 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same |
| 04/28/1999 | EP0910396A1 Isolated, nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof |
| 04/28/1999 | EP0910387A1 Apoptosis associated protein bbk |
| 04/28/1999 | EP0910243A2 Il-5 transgenic mouse |
| 04/28/1999 | EP0910239A2 Transformation of cotton plants |
| 04/28/1999 | EP0876509A4 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 04/28/1999 | EP0789705A4 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy |
| 04/28/1999 | EP0775150B1 Endotoxin reduction or removal process |
| 04/28/1999 | EP0753010A4 A novel expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins |
| 04/28/1999 | EP0723555A4 Chimeric proteins which block complement activation |
| 04/28/1999 | EP0675967A4 Functional assay for tumor suppressor genes. |